Literature DB >> 23242967

SDF-1alpha G801A polymorphism in Southern Iranian patients with colorectal and gastric cancers.

Mahboobeh Razmkhah1, Abbas Ghaderi.   

Abstract

BACKGROUND: A single nucleotide polymorphism (SNP) in the stromal cell-derived factor-1 (SDF-1) gene at position 801 (G>A) is associated with susceptibility to certain tumors. This study aimed to investigate an association between this SNP and colorectal and gastric cancers in an Iranian population.
METHOD: Genotype and allele frequencies of SDF-1 801 G>A were assessed using polymerase chain reaction-restriction fragment length polymorphism in 109 patients with colorectal cancer, 124 with gastric cancer, and 262 normal control volunteers.
RESULTS: No statistically significant difference was observed in the frequencies of genotypes and alleles between patients and controls (p > 0.05).
CONCLUSION: SDF-1 gene polymorphism at position 801 (G>A) was not associated with colorectal and gastric cancers in Southern Iranian patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23242967     DOI: 10.1007/s12664-012-0283-0

Source DB:  PubMed          Journal:  Indian J Gastroenterol        ISSN: 0254-8860


  30 in total

Review 1.  Functions of CXCL12 and CXCR4 in breast cancer.

Authors:  Kathryn E Luker; Gary D Luker
Journal:  Cancer Lett       Date:  2005-07-25       Impact factor: 8.679

2.  Polymorphism and circulating levels of the chemokine CXCL12 in colorectal cancer patients.

Authors:  Jan Dimberg; Anders Hugander; Sture Löfgren; Dick Wågsäter
Journal:  Int J Mol Med       Date:  2007-01       Impact factor: 4.101

3.  Stromal cell-derived factor-1 (SDF-1) alleles and susceptibility to breast carcinoma.

Authors:  Mahboobeh Razmkhah; Abdul-Rasoul Talei; Mehrnoosh Doroudchi; Tahereh Khalili-Azad; Abbas Ghaderi
Journal:  Cancer Lett       Date:  2004-12-13       Impact factor: 8.679

4.  CXCL12 rs1801157 polymorphism and expression in peripheral blood from breast cancer patients.

Authors:  Karen Brajão de Oliveira; Roberta Losi Guembarovski; Julie Massayo Maeda Oda; Mário Sérgio Mantovani; Clisia Mara Carrera; Edna Maria Vissoci Reiche; Julio Cesar Voltarelli; Ana Cristina da Silva do Amaral Herrera; Maria Angelica Ehara Watanabe
Journal:  Cytokine       Date:  2011-05-17       Impact factor: 3.861

5.  Analysis of the stromal cell-derived factor 1-3'A gene polymorphism in pancreatic cancer.

Authors:  George E Theodoropoulos; George S Panoussopoulos; Nikolaos V Michalopoulos; Constantinos P Zambirinis; Stiliani Taka; Paraskevas Stamopoulos; Maria Gazouli; G Zografos
Journal:  Mol Med Rep       Date:  2010 Jul-Aug       Impact factor: 2.952

6.  CXCL-12/stromal cell-derived factor-1alpha transactivates HER2-neu in breast cancer cells by a novel pathway involving Src kinase activation.

Authors:  Neslihan Cabioglu; Justin Summy; Claudia Miller; Nila U Parikh; Aysegul A Sahin; Sitki Tuzlali; Kevin Pumiglia; Gary E Gallick; Janet E Price
Journal:  Cancer Res       Date:  2005-08-01       Impact factor: 12.701

7.  CXCL12, CXCR4 and CXCR7 expression in brain metastases.

Authors:  Andrea Salmaggi; Emanuela Maderna; Chiara Calatozzolo; Paola Gaviani; Alessandra Canazza; Ida Milanesi; Antonio Silvani; Francesco DiMeco; Antonino Carbone; Bianca Pollo
Journal:  Cancer Biol Ther       Date:  2009-09-06       Impact factor: 4.742

8.  CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature.

Authors:  Zhenhua Miao; Kathryn E Luker; Bretton C Summers; Rob Berahovich; Mahaveer S Bhojani; Alnawaz Rehemtulla; Celina G Kleer; Jeffrey J Essner; Aidas Nasevicius; Gary D Luker; Maureen C Howard; Thomas J Schall
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-26       Impact factor: 11.205

9.  A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1)

Authors:  C C Bleul; R C Fuhlbrigge; J M Casasnovas; A Aiuti; T A Springer
Journal:  J Exp Med       Date:  1996-09-01       Impact factor: 14.307

10.  Stromal cell derived factor-1: its influence on invasiveness and migration of breast cancer cells in vitro, and its association with prognosis and survival in human breast cancer.

Authors:  Hua Kang; Gareth Watkins; Christian Parr; Anthony Douglas-Jones; Robert E Mansel; Wen G Jiang
Journal:  Breast Cancer Res       Date:  2005-04-04       Impact factor: 6.466

View more
  7 in total

1.  CXCL12 G801A polymorphism and cancer risk: An updated meta-analysis.

Authors:  Dan Meng; Yin-Xiang Wu; Vidhi Heerah; Shuang Peng; Meng-di Chu; Yong-Jian Xu; Wei-Ning Xiong; Shu-Yun Xu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-06-14

2.  The association between SDF-1 G801A polymorphism and non-small cell lung cancer risk in a Chinese Han population.

Authors:  Weiguo Xu; Rong Cui; Huapeng Yu
Journal:  Int J Clin Exp Med       Date:  2015-08-15

3.  The CXCL12 G801A polymorphism is associated with cancer risk: a meta-analysis.

Authors:  Ke Zhu; Benchun Jiang; Rong Hu; Ying Yang; Miao Miao; Yingchun Li; Zhuogang Liu
Journal:  PLoS One       Date:  2014-09-30       Impact factor: 3.240

4.  The CXCL12 rs1801157 polymorphism and risk of colorectal cancer: a meta-analysis.

Authors:  Ke Xu; Hong Dai; Shaolong Wang; Jie Zhang; Tao Liu
Journal:  Onco Targets Ther       Date:  2018-05-01       Impact factor: 4.147

5.  MicroRNA-binding site polymorphisms and risk of colorectal cancer: A systematic review and meta-analysis.

Authors:  Morteza Gholami; Bagher Larijani; Farshad Sharifi; Shirin Hasani-Ranjbar; Reza Taslimi; Milad Bastami; Rasha Atlasi; Mahsa M Amoli
Journal:  Cancer Med       Date:  2019-10-21       Impact factor: 4.452

6.  The SDF-1 rs1801157 Polymorphism is Associated with Cancer Risk: An Update Pooled Analysis and FPRP Test of 17,876 Participants.

Authors:  Xiang Tong; Yao Ma; Huajiang Deng; Xixi Wang; Sitong Liu; Zhipeng Yan; Shifeng Peng; Hong Fan
Journal:  Sci Rep       Date:  2016-06-06       Impact factor: 4.379

Review 7.  Epidemiologic Study of Gastric Cancer in Iran: A Systematic Review.

Authors:  Khadijeh Kalan Farmanfarma; Neda Mahdavifar; Soheil Hassanipour; Hamid Salehiniya
Journal:  Clin Exp Gastroenterol       Date:  2020-11-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.